2. Academic Validation
  3. TNIK inhibition abrogates colorectal cancer stemness

TNIK inhibition abrogates colorectal cancer stemness

  • Nat Commun. 2016 Aug 26;7:12586. doi: 10.1038/ncomms12586.
Mari Masuda 1,  Yuko Uno 2,  Naomi Ohbayashi 3,  Hirokazu Ohata 4,  Ayako Mimata 1,  Mutsuko Kukimoto-Niino 3,  Hideki Moriyama 2,  Shigeki Kashimoto 2,  Tomoko Inoue 2,  Naoko Goto 1,  Koji Okamoto 4,  Mikako Shirouzu 3,  Masaaki Sawa 2,  Tesshi Yamada 1
Affiliations

Affiliations

  • 1 Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
  • 2 Carna Biosciences, Inc., BMA 3F 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
  • 3 Division of Structural and Synthetic Biology, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
  • 4 Division of Cancer Differentiation, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
PMID: 27562646 DOI: 10.1038/ncomms12586
Abstract

Canonical Wnt/β-catenin signalling is essential for maintaining intestinal stem cells, and its constitutive activation has been implicated in colorectal carcinogenesis. We and Others have previously identified Traf2- and Nck-interacting kinase (TNIK) as an essential regulatory component of the T-cell factor-4 and β-catenin transcriptional complex. Consistent with this, Tnik-deficient mice are resistant to azoxymethane-induced colon tumorigenesis, and Tnik(-/-)/APC(min/+) mutant mice develop significantly fewer intestinal tumours. Here we report the first orally available small-molecule TNIK inhibitor, NCB-0846, having anti-Wnt activity. X-ray co-crystal structure analysis reveals that NCB-0846 binds to TNIK in an inactive conformation, and this binding mode seems to be essential for Wnt inhibition. NCB-0846 suppresses Wnt-driven intestinal tumorigenesis in APC(min/+) mice and the sphere- and tumour-forming activities of colorectal Cancer cells. TNIK is required for the tumour-initiating function of colorectal Cancer Stem Cells. Its inhibition is a promising therapeutic approach.

Figures
Products